Mohs surgery: Commentaries and controversies

International Journal of Dermatology

Volumn 44, Issue 11, 2005, Pages 893-905

  Garcia, Carlos ^a,b,c   Holman, Jennifer ^a,b,c   Poletti, Eduardo ^a,b,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b University of Missouri   (United States)

^c UNIVERSIDAD AUTÓNOMA DE AGUASCALIENTES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL CELL CARCINOMA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMOSURGERY; CLINICAL STUDY; COST EFFECTIVENESS ANALYSIS; CRYOSURGERY; CURETTAGE; DERMATOFIBROSARCOMA PROTUBERANS; ELECTROSURGERY; EVIDENCE BASED MEDICINE; EXTERNAL EAR; EYELID CARCINOMA; FIBROXANTHOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MELANOMA; MERKEL CELL TUMOR; MICROSURGERY; PATIENT SELECTION; REVIEW; SKIN CANCER; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SKIN NEOPLASMS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL RATE;

EID: 28444498423     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02689.x     Document Type: Review

References (79)

1. Fleischman M, Garcia C. Informed consent in dermatologic surgery. Dermatol Surg 2003; 29: 952-955.
2. Rowe DEE, Carroll RJ, Day CL. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 5: 315-28.
3. Gooding C, White G, Yatsuhashi M. Significance of marginal excision in excised basal cell carcinoma. N Engl J med 1965; 273: 923-925.
4. Pascal R, Hobby L, Lattes R, Crikelair G. Prognosis of an "incompletely excised" versus "completely excised" basal cell carcinoma. Plast Reconstr Surg 1968; 41: 328-332.
5. Bumsted RM, Ceilleey RI, Panje WR, et al. Auricular malignant neoplasms. When is chemotherapy (Mohs' technique) necessary? Archives of Otolaryngology 1981; 107: 711-4.
6. Downes RN, Walker NPJ, Collin JRO. Micrographic (Mohs') surgery in the management of periocular basal cell epitheliomas. Eye 1990; 4: 160-168.
7. Mohs F. Carcinoma of the skin: A summary of therapeutic results. In: Charles C Thomas, ed. Chemosurgery, Microscopically Controlled Surgery for Skin Cancer. Springfield, IL, 1978: 153-164, 358-364.
8. Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas, part 1. J Dermatol Surg Oncol 1991; 17: 713-718.
9. Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas, part 2. J Dermatol Surg Oncol 1991; 17: 720-726.
10. Silverman MK, Kopf AW, Bart RS, et al. Recurrence rates of treated basal cell carcinomas, Part 3. J Dermatol Surg Oncol 1992; 18: 471-476.
11. Silverman MK, Kopf AW, Bart RS, et al. Recurrence rates of treated basal cell carcinomas, Part 4. J Dermatol Surg Oncol 1992; 18: 549-554.
12. Thissen MR, Neumann MH, Schoutn LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999; 1135: 1177-1183.
13. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990; 23: 1118-1126.
14. Hendrix JD, Jr, Parlette HL. Micronodular basal cell carcinoma. A deceptive histologic subtype with frequently undetected tumor extension. Arch Dermatol 1996; 132: 295-298.
15. Salasche SJ, Amonette RA. Morpheaform basal cell epitheliomas. A study of subclinical extensions in a series of 51 cases. J Dermatol Surg Oncol 1981; 7: 387-394.
16. Randle HW. Basal cell carcinoma. Identification and treatment of the high-risk patient. Dermatol Srug 1996; 22: 255-261.
17. Ratner D, Lowe L, Johnson TM, et al. Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer 2000; 88: 1605-1613.
18. Cook J, Zitelli JA. Mobs micrographic surgery: a cost analysis. J Am Acad Dermatol 1998; 39: 698-703.
19. Dzubow LM, Rigel DS, Robins P. Risk factors for local recurrence of primary cutaneous squamous cell carcinomas. Treatment by microscopically controlled excision. Arch Dermatol 1982; 118: 900-902.
20. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 1992; 26: 976-990.
21. Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip. An analysis of twenty-seven cases. J Am Acad Dermatol 1989; 21: 241-248.
22. Holmkvist KA, Roenigk RK. Squamous cell carcinoma of the lip treated with Mohs micrographic surgery: outcome at 5 years. J Am Acad Dermatol 1998; 28: 960-966.
23. Feasel AM, Brown TJ, Bogle MA, et al. Perineural invasion of cutaneous malignancies. Dermatol Surg 2001; 27: 531-542.
24. Mohs F, Larson P, Iriondo M. Micrographic surgery for the microscopically controlled excision of carcinoma of the external ear. J Am Acad Dermatol 1988; 19: 729-737.
25. Mohs FE. Micrographic surgery for the microscopically controlled excision of eyelid cancers. Arch Ophtalmol 1986; 104: 901-909.
26. Leshin B, Yeatts P, Anscher M, et al. Management of periocular basal cell carcinoma: Mohs' micrographic surgery versus radiotherapy. Surv Ophtalmol 1993; 38: 193-212.
27. Zitelli JA, Braun CD, Hanusa BH. Surgical margins for excision of primary cutaneous melanomas. J Am Acad Dermatol 1997; 37: 422-429.
28. Snow SN, Mohs F, Oriba HA, et al. Cutaneous malignant melanoma treated by Mohs surgery: review of the treatment results of 179 cases from the Mohs Melanoma Registry. Dermatol Surg 1997; 23: 1055-1060.
29. Brodland D. The treatment of nail apparatus melanoma with Mohs micrographic surgery. Dermatol Surg 2001; 27: 269-273.
30. Barlow RJ, White CR, Swanson NA. Mohs; micrographic surgyer using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ. Br J Dermatol 2002; 146: 290-294.
31. Donato R. S-100 proteins. Cell Calcium 1986; 7: 113-145.
32. Blessing K, Sanders DSA, Grant JJH. Comparison of immunohistochemical staining of the novel antibody Melan-A with S-100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 1998; 32: 139-146.
33. Bhawan J. Mel-5: a novel antibody for differential diagnosis of epidermal pigmented lesions of the skin in paraffin embedded sections. Melanoma Res 1997; 7: 43-48.
34. Bacchi C, Bonetti F, Pea M, et al. HMB-45: a review. Appl Immunohistochem 1996; 4: 73-85.
35. Chiamenti A, Vella F, Bonetti F, et al. Anti-melanoma antibody HMB-45 recognizes a 30-35 kDa melanosome associated sialated glycoprotein. Melanoma Res 1996; 6: 291-298.
36. Jungbluth A, Busam KJ, Gerald WL, et al. A103: an anti-Melan-A monoclonal antibody for the detection of malignant melanoma in paraffin embedded tissue. Am J Surg Pathol 1998; 22: 595-602.
37. Busam K, Chen YT, Old LJ, et al. Expression of Melan-A (MART-1) in benign melanocytic nevi and primary cutaneous melanoma. Am J Surg Pathol 1998; 22: 976-982.
38. Robinson JK. Margin control for lentigo maligna. J Am Acad Dermatol 1994; 31: 79-85.
39. Zalla MJ, Lim KK, Dicuado DJ, et al. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg 2000; 26: 771-784.
40. Cohen LM, McCall MW, Zax RH. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma: a follow-up study. Dermatol Surg 1998; 24: 673-677.
41. Wolf Y, Balicer RD, Amir A, et al. The vertical dimension in the surgical treatment of cutaneous malignant melanoma. Eur J Plast Surg 2001; 24: 74-77.
42. Snow S, Madjar DD, Hardy S, et al. Microcystic adnexal carcinoma: report of 13 cases and review of the literature. Dermatol Surg 2001; 27: 401-8.
43. Huether MJ, Zitelli JA, Brodland DG. Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol 2001; 44: 656-659.
44. Jensen ML, Jensen OM, Michalski W, et al. Intradermal and subcutaneous leiomyosarcoma. a clinicopathological and immunohistochemical study of 41 cases. J Cutan Pathol 1996; 23: 458-463.
45. Oliver GF, Reiman HM, Gonchoroff NJ, et al. Cutaneous and subcutaneous leiomyosarcoma. a clinicopathological review of 14 cases with reference to antidesmin staining and nuclear DNA patterns studied by flow cytometry. Br J Dermatol 1991; 124: 252-257.
46. Swanson PE, Stanley MW, Scheithauer BW, et al. Primary cutaneous leiomyosarcoma: a histological and immunohistochemical study of 9 cases with ultrastructural correlation. J Cutan Pathol 1988; 115: 129-141.
47. Bernstein SPINAL CORD, Roenigk RK. Leiomyosarcoma of the skin: treatment of 34 cases. Dermatol Surg 1996; 7: 631-635.
48. Fretzin DF, Helwig EB. Atypical Fibroxanthoma of the skin: a clinicopathologic stydu of 140 cases. Cancer 1973; 31: 1541-1552.
49. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972 1998; 105: 107.
50. Smith PD, Patterson JW. Merkel cell carcinoma (neuro endocrine carcinoma of the skin). Am J Clin Pathol 2001; 115 (Suppl 1): 568-578.
51. Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the heard and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001; 127: 149-154.
52. Coit D. Merkel cell carcinoma. Ann Surg Oncol 2001; 8: 204-208.
53. O'Connor WJ, Roenigk RK, Brodland DG. Merkel cell carcinoma: Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997; 23: 929-933.
54. Boyer JD, Zitelli JA, Brodland DG, et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002; 47: 885-892.
55. Brissett AE, Olson KD, Kasperbauer JL, et al. Merkel cell carcinoma of the head and neck: a retrospective case series. Head & Neck 2002; 24: 982-988.
56. Park GC, Shelton JB Jr, Ow RA, et al. Merkel cell carcinoma of the lower lip: a case report and histopathologic study. Arch Otolaryngol Head Neck Surg 1999; 125: 907-911.
57. Esmaeli B, Naderi A, Hidaji L, et al. Merkel cell carcinoma of the eyelid with a positive sentinel node. Arch Ophtalmol 2002; 120: 646-648.
58. Colombo F, Holbach LM, Junemann A, et al. Merkel cell carcinoma: clinicopathologic correlation, management and follow-up in five patients. Ophtal Plast Reconst Surg 2000; 16: 453-458.
59. Duker I, Starz H, Bachter D, et al. Prognostic and therapeutic implications of sentinel lymphadenectomy and S-staging in Merkel cell carcinoma. Dermatol 2001; 202: 225-229.
60. Rigel DS, Robins P, Friedman RJ. Predicting recurrence of basal-cell carcinomas treated by microscopically controlled excision: a recurrence index score. J Dermatol Surg Oncol 1981; 7: 807-810.
61. Hruza GJ. Mohs micrographic surgery local recurrences. J Dermatol Surg Oncol 1994; 20: 573-577.
62. Katz KH, Helm KF, Billingsleey EM, et al. Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery. J Am Acad Dermatol 2001; 45: 231-238.
63. Lawrence CM. Mohs micrographic surgery for basal cell carcinoma. Br J Plast Surg 1993; 46: 599-606.
64. Sheridan AT, Dawber RPR. Curettage, electrosurgery and skin cancer. Australas J Dermatol 2000; 41: 19-30.
65. Knox JM, Lyles TW, Shapiro EM, et al. Curettage and electrodessication in the treatment of skin cancer. Arch Dermatol 1960; 82: 197-203.
66. Freeman RG, Knox LM. Recent experience with skin cancer. Arch Dermatol 1970; 101: 403-408.
67. Tromovitch TA, Beirne G, Beirne C. Cancer chemosurgery (Mohs technique). The "chemo-check":. Arch Dermatol 1965; 92: 291-2.
68. Knox JM, Freeman RG, Duncan WC, et al. Treatment of skin cancer. South Med J 1967; 60: 241-246.
69. Kopf AW, Bart RS, Schrager D, et al. Curettage-electrodessication treatment of basal cell carcinomas. Arch Dermatol 1977; 113: 439-443.
70. Spiller WF, Spiller RF. Treatment of basal cell epitheliomas by curettage and electrodessication. J Am Acad Dermatol 1984; 11: 808-814.
71. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinomas. J Dermatol Surg Oncol 1989; 15: 315-328.
72. Kuflik EG. Cryosurgery for cutaneous malignancy: an update. Dermatol Surg 1997; 23: 1081-1087.
73. Zacarian SA. Cryosurgery of cutaneous carcinomas. an eighteen year study of 3022 patients with 4028 carcinomas. J Am Acad Dermatol 1983; 9: 947-956.
74. Graham GF. Advances in cryosurgery during the past decade. Cutis 1993; 52: 365-372.
75. Holt P. Cryosurgery for skin cancer results over a 5-year period using liquid nitrogen spray cryotherapy. Br J Dermatol 1988; 119: 231-240.
76. Goncalves JC, Martins C. Debulking of skin cancers with radiofrequency before cryosurgery. Dermatol Surg 1997; 23: 253-256.
77. Nordin P, Stenquist B. Five-year results of curettage-cryosurgery for 100 consecutive auricular non-melanoma skin cancers. J Laryngol Otol 2002; 116: 893-898.
78. Johnson TM, Tromovitch TA, Swanson NA. Combined curettage and excision: a treatment method for primary basal cell carcinoma. J Am Acad Dermatol 1991; 24: 613-617.
79. Morrison WH, Garden AS, and KK. Radiation therapy for non-melanoma skin carcinomas. Clin Plast Surg 1997; 24: 719-729.